(Q53484529)

14 May 2018

title

Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. (English)

1 reference

14 May 2018

author

Derek S. Brown

1

1 reference

14 May 2018

author name string

F Reed Johnson

2

1 reference

14 May 2018

Christine Poulos

3

1 reference

14 May 2018

Mark L Messonnier

4

1 reference

14 May 2018

language of work or name

English

0 references

publication date

29 December 2009

1 reference

14 May 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

14 May 2018

volume

28

1 reference

14 May 2018

issue

7

1 reference

14 May 2018

page(s)

1702-1708

1 reference

14 May 2018

Prevalence of HPV infection among females in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Chapter 2: The burden of HPV-related cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Review of the economic and quality-of-life burden of cervical human papillomavirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Health and economic implications of HPV vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Economic evaluation of human papillomavirus vaccination in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Model for assessing human papillomavirus vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Human papillomavirus and HPV vaccines: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Vaccination to prevent and treat cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Using conjoint analysis to elicit preferences for health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Parental Attitudes About Sexually Transmitted Infection Vaccination for Their Adolescent Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Acceptability to Latino parents of sexually transmitted infection vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

The demand for a dengue vaccine: a contingent valuation survey in Metro Manila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Private demand for cholera vaccines in Beira, Mozambique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Cost–benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Estimating older adults' preferences for walking programs via conjoint analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Adolescent immunization delivery in school-based health centers: a national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

A randomized study of financial incentives to increase physical activity among sedentary older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

'Irrational' stated preferences: a quantitative and qualitative investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Discrete choice experiments to measure consumer preferences for health and healthcare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

Best--worst scaling: What it can do for health care research and how to do it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.024

10.1016/J.VACCINE.2009.12.024

7 January 2021

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018